Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply

Fariz Yahya; Karl Gaffney; Louise Hamilton; Ellie Lonsdale; Jane Leeder; Alan Brooksby; Charlotte Cavill; Joshua Berry-Jenkins; Cathal Boyle; Debbie Bond; Raj Sengupta

doi:10.1093/rap/rky037

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply

Fariz Yahya, Karl Gaffney, Louise Hamilton, Ellie Lonsdale, Jane Leeder, Alan Brooksby, Charlotte Cavill, Joshua Berry-Jenkins, Cathal Boyle, Debbie Bond, Raj Sengupta

Department of Life Sciences

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1
Number of pages	1
Journal	Rheumatology Advances in Practice
Volume	2
Issue number	2
DOIs	https://doi.org/10.1093/rap/rky037
Publication status	Published - 18 Oct 2018

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1093/rap/rky037Licence: CC BY-NC

Cite this

Yahya, F., Gaffney, K., Hamilton, L., Lonsdale, E., Leeder, J., Brooksby, A., Cavill, C., Berry-Jenkins, J., Boyle, C., Bond, D., & Sengupta, R. (2018). Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply. Rheumatology Advances in Practice, 2(2), 1. https://doi.org/10.1093/rap/rky037

Yahya, F, Gaffney, K, Hamilton, L, Lonsdale, E, Leeder, J, Brooksby, A, Cavill, C, Berry-Jenkins, J, Boyle, C, Bond, D & Sengupta, R 2018, 'Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply', Rheumatology Advances in Practice, vol. 2, no. 2, pp. 1. https://doi.org/10.1093/rap/rky037

@article{ef7fc719d583427f9816d065036d283f,

title = "Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply",

author = "Fariz Yahya and Karl Gaffney and Louise Hamilton and Ellie Lonsdale and Jane Leeder and Alan Brooksby and Charlotte Cavill and Joshua Berry-Jenkins and Cathal Boyle and Debbie Bond and Raj Sengupta",

year = "2018",

month = oct,

day = "18",

doi = "10.1093/rap/rky037",

language = "English",

volume = "2",

pages = "1",

journal = "Rheumatology Advances in Practice",

issn = "2514-1775",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Comment on

T2 - Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply

AU - Yahya, Fariz

AU - Gaffney, Karl

AU - Hamilton, Louise

AU - Lonsdale, Ellie

AU - Leeder, Jane

AU - Brooksby, Alan

AU - Cavill, Charlotte

AU - Berry-Jenkins, Joshua

AU - Boyle, Cathal

AU - Bond, Debbie

AU - Sengupta, Raj

PY - 2018/10/18

Y1 - 2018/10/18

UR - http://www.scopus.com/inward/record.url?scp=85063180297&partnerID=8YFLogxK

U2 - 10.1093/rap/rky037

DO - 10.1093/rap/rky037

M3 - Letter

AN - SCOPUS:85063180297

SN - 2514-1775

VL - 2

SP - 1

JO - Rheumatology Advances in Practice

JF - Rheumatology Advances in Practice

IS - 2

ER -

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this